IQ-AI Ltd (LON:IQAI) said its subsidiary Imaging Biometrics (IB) has released an upgraded version of its IB Clinic software platform.
The company said that the new release incorporates multiple new enhancement requests for the platform received from clients, as well as workflow efficiencies engineered by IB’s developers.
READ: IQ-AI shares surges as liver nodule software gets green light in Europe
“Ultimately, this release underscores IB’s commitment to quality and helping clinicians improve care for their patients”, IQ-AI said.
IB Clinic consists of multiple software functions including perfusion-weighted imaging and permeability computation modules IB Neuro and IB DCE, diffusion-weighted imaging analysis module IB Diffusion, image co-registration and manipulation module IB Delta Suite, and IB Rad Tech, which streamlines and automates customisable workflows.
“This latest release further builds upon our proven track record of delivering scientifically proven advancements to clinicians”, IB chief executive Michael Schmainda said in a statement.